General Malignant Mesothelioma


Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing... Continue Reading

Stay on Top of Your Family History of Cancer (July 15, 2011)

People who are at high risk of cancer as a result of their family history may be advised to undergo earlier or more intensive cancer screening. Because family history of cancer can change over time, it’s... Continue Reading

MVP Does Not Provide Benefit in Mesothelioma Patients (May 21, 2008)

MVP Does Not Provide Benefit in Mesothelioma Patients The chemotherapy agent Navelbine® (vinorelbine) may improve outcomes for patients with malignant pleural mesothelioma. However, the combination chemotherapy... Continue Reading

Minimally Invasive Endoscopic Procedure Shows Promise for Detecting Lung Cancer (February 8, 2008)

Minimally Invasive Endoscopic Procedure Shows Promise for Detecting Lung Cancer Use of a minimally invasive technique called endoscopy to detect lung cancer may be more effective than more complicated... Continue Reading

Malignant Pleural Mesothelioma Updates (November 7, 2007)

Malignant Pleural Mesothelioma Updates: Highlights from the 12th World Conference on Lung Cancer Introduction Malignant pleural mesothelioma (MPM) is a tumor that arises from the surfaces of the pleural... Continue Reading

Alimta®/Platinum-compound Combination Confirmed Active in Mesothelioma (June 26, 2007)

Alimta®/Platinum-compound Combination Confirmed Active in Mesothelioma According to results recently presented at the 2007 annual meeting of the American Society of Clinical Oncology, the chemotherapy... Continue Reading

Alimta® Alone or with Platinol® Benefits Patients with Recurrent Mesothelioma (August 3, 2006)

Alimta® Alone or with Platinol® Benefits Patients with Recurrent Mesothelioma According to results recently published in the Journal of Thoracic Oncology, treatment with the chemotherapy agent Alimta®... Continue Reading

ONCONASE® Improves Survival in Inoperable Mesothelioma (May 10, 2006)

ONCONASE® Improves Survival in Inoperable Mesothelioma According to a press release from Alfacell Corporation, the addition of ONCONASE® (ranpirnase) to Adriamycin® (doxorubicin) improves survival over... Continue Reading

Sequential Chemotherapy for Pleural Mesothelioma Promising (April 12, 2006)

Sequential Chemotherapy for Pleural Mesothelioma Promising According to results published in the journal Lung Cancer, sequential administration of chemotherapy including cisplatin (Platinol®) and gemcitabine... Continue Reading

Alimta® and Paraplatin® Effective and Well-Tolerated in Mesothelioma (March 22, 2006)

Alimta® and Paraplatin® Effective and Well-Tolerated in Mesothelioma According to an article recently published in the Journal of Clinical Oncology, the treatment combination consisting of Alimta® (pemetrexed)... Continue Reading

Early Chemotherapy Improves Outcomes for Mesothelioma (February 9, 2006)

Early Chemotherapy Improves Outcomes for Mesothelioma According to a recent article published in the Annals of Oncology, immediate treatment with chemotherapy improves survival rates at one year and provides... Continue Reading

Osteopontin: Marker for Mesothelioma (October 13, 2005)

Osteopontin: Marker for Mesothelioma According to a recent article published in the New England Journal of Medicine, the protein osteopontin, which can be found in circulating blood, may help in the... Continue Reading

Combination of Cisplatin and Raltitrexed Improves Survival with Mesothelioma (October 5, 2005)

Combination of Cisplatin and Raltitrexed Improves Survival with Mesothelioma According to the results of a phase III clinical trial published in the Journal of Clinical Oncology, treatment with both cisplatin... Continue Reading

Current Model Remains the Standard for the Prognosis of Malignant Pleural Mesothelioma (January 18, 2005)

Current Model Remains the Standard for the Prognosis of Malignant Pleural Mesothelioma A recent article in the Journal of Clinical Oncology reports that the current model for determining the prognosis... Continue Reading

Surgery After Chemotherapy Shows Promise for Patients With Mesothelioma (October 4, 2004)

Surgery After Chemotherapy Shows Promise for Patients With Mesothelioma Results from a recent study published in the Journal of Clinical Oncology indicate that neoadjuvant chemotherapy appears promising... Continue Reading

Alimta®/Cisplatin Combination Approved for Malignant Pleural Mesothelioma (February 9, 2004)

Alimta®/Cisplatin Combination Approved for Malignant Pleural Mesothelioma Alimta® (pemetrexed) in combination with cisplatin (Platinol®) was recently approved by the United... Continue Reading

Possible Marker for Mesothelioma (December 1, 2003)

Possible Marker for Mesothelioma According to results recently published in The Lancet, proteins found in the blood may provide a marker for the detection of mesothelioma in patients who have... Continue Reading

One Year Survival Improved with the Addition of Alimta® to Platinol® in Malignant Pleural Mesothelioma (July 23, 2003)

One Year Survival Improved with the Addition of Alimta® to Platinol® in Malignant Pleural Mesothelioma According to results recently published in The Journal of Clinical Oncology,... Continue Reading

Next Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS